CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
15. Mai 2024 17:17 ET
|
Centogene NV
Reported Full Year 2023 total revenues of 2% growth at €48.5 millionSecured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company owned...
CENTOGENE Announces Preliminary Full Year 2023 Revenue
18. Januar 2024 06:30 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
CENTOGENE Reports First Half 2023 Financial Results
07. September 2023 17:00 ET
|
Centogene NV
First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue...
Edge Total Intelligence Inc. Reports Second Quarter 2023 and Consolidated 2023 Results
29. August 2023 19:39 ET
|
Edge Total Intelligence Inc.
ARLINGTON, Va., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Edge Total Intelligence Inc. (TSXV: CTRL, OTC: UNFYF, FSE: Q5i)(“edgeTI”, “we”, “our” or the “Company”), a leader in real-time digital operations,...
CENTOGENE Reports Full Year 2022 Financial Results
16. Mai 2023 18:25 ET
|
Centogene NV
Full Year 2022 total revenues with double-digit growth of 12% at €47.5 million, in line with prior guidanceSignificant expansion of gross profit margin from 32% to 42% and ongoing cost control...
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
22. Dezember 2022 16:00 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
CENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results
30. März 2022 07:30 ET
|
Centogene NV
- Full Year 2021 Total Revenue Growth of 48%, and 11% in Core Business Segments, Exceeds Guidance - Focus on Pharma and Diagnostics to Position for Strong Performance in 2022 - Closed $62 Million...
CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022
23. März 2022 06:30 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 23, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to...
CENTOGENE Reports Third Quarter 2021 Financial Results
24. November 2021 07:35 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
Nubeva Announces Q2 Fiscal 2021 Financial Results
16. Dezember 2020 07:00 ET
|
Nubeva Technologies
SAN JOSE, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Nubeva Technologies Ltd. ("Nubeva" or the "Company") (TSX-V: NBVA), announces its unaudited consolidated financial statements for the second...